Vyking Ventures Invests in Dopamine Sports Tech Fund

Vyking Ventures, the investment arm of Vyking, has invested in Dopamine Sports Ventures, an early-stage and growth investment fund focused on sports technology companies.

The investment supports Dopamine’s objective of identifying and backing companies with the potential to become category leaders across the sports technology sector. It also extends Vyking Ventures’ investment focus across gaming, technology and next-generation player and fan engagement into the growing sports technology market.

Dopamine was established through a network of angel investors and operators from the sports, entertainment and media industries. After developing its investment track record through an initial self-funded vehicle, the group is now deploying capital through its second fund, a specialised vehicle targeting early-stage and growth-stage companies in sports technology and related areas.

The fund takes a selective approach to investments, combining capital with the operational experience, industry connections and strategic support of its founding partners.

Dopamine is led by founding partners Andreas Meinrad, Barry McNeill and Markus Egger, who collectively bring extensive leadership and operating experience spanning sports, entertainment, media and technology. The fund is also developing a wider network of entrepreneurs, specialists and industry practitioners, providing portfolio companies with access to sector expertise and relationships beyond financial investment.

For Vyking Ventures, the investment complements Vyking’s background in iGaming, platform engineering and crypto-native infrastructure. It also reflects the investment arm’s belief that relationships and industry knowledge remain important alongside technology when identifying and developing category-leading companies.

Vyking CEO Franz Gerhart said the convergence between sports and gaming is accelerating and highlighted Dopamine’s network and operational experience as key reasons for the investment. He added that Vyking looks forward to supporting the fund’s portfolio companies as they grow.

Dopamine founding partner Markus Egger welcomed Vyking Ventures to the fund, pointing to the expertise and network the team brings. He also emphasised the continued importance of trusted human relationships in the investment sector despite advances in technology and tools.

Through the investment, Vyking Ventures will support Dopamine’s continued portfolio development, its backing of sports technology founders and the expansion of its network across the international sports industry.